VINCRISTINE |
LEUROCRISTINE |
NSC-67574 |
LEUROCRISTINE SULFATE |
VINCRISTIN |
ONCOVIN® |
22-OXOVINCALEUKOBLASTINE |
VINCRISTINUM |
KYOCRISTINE |
22-OXOVINCALEUKOBLASTIN |
VINCRISTINA |
pubchem.compound:5978 |
chemidplus:57-22-7 |
rxcui:11202 |
chembl:CHEMBL90555 |
drugbank:00541 |
Drug Categories | tubulin modulators |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antineoplastic agent |
Year of Approval | 1963 |
Drug Class | antineoplastic agents |
Drug Categories | agents causing muscle toxicity |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | bsep/abcb11 substrates with narrow therapeutic index |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | narrow therapeutic index drugs |
Drug Categories | neurotoxic agents |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | oatp1b3 inhibitors |
Drug Categories | p-glycoprotein inducers |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | p-glycoprotein substrates with narrow therapeutic index |
VINCRISTINE | DrugBank Drug Name |
57-22-7 | CAS Number |
Alcavixin | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
VINCRISTINE | Primary Drug Name |
Drug Class | antineoplastic agents |
Year of Approval | 1963 |
Drug Indications | antineoplastic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL90555 | ChEMBL Drug ID |
C933 | NCI drug code |
D09QVV | TTD Drug ID |
VINCRISTINE | GuideToPharmacology Ligand Name |